STATE STREET CORP - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 163 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2023. The put-call ratio across all filers is 2.13 and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q3 2023$3,848,647
-92.3%
1,131,955
-83.3%
0.00%
-100.0%
Q2 2023$49,936,958
-10.8%
6,794,144
+25.7%
0.00%0.0%
Q1 2023$56,001,498
-59.2%
5,405,550
-53.5%
0.00%
-25.0%
Q4 2022$137,420,098
+51.7%
11,635,910
+169.6%
0.00%
-33.3%
Q3 2022$90,599,000
-29.7%
4,316,310
+4.0%
0.01%
-25.0%
Q2 2022$128,836,000
-9.6%
4,150,632
+19.6%
0.01%
+14.3%
Q1 2022$142,456,000
+8.1%
3,469,470
+14.4%
0.01%
+16.7%
Q4 2021$131,833,000
+9.5%
3,032,727
+26.1%
0.01%0.0%
Q3 2021$120,398,000
-10.3%
2,404,590
+12.8%
0.01%
-14.3%
Q2 2021$134,261,000
-24.5%
2,131,463
+11.4%
0.01%
-30.0%
Q1 2021$177,781,000
-7.5%
1,913,479
-10.8%
0.01%
-16.7%
Q4 2020$192,245,000
-0.1%
2,145,591
+15.2%
0.01%
-7.7%
Q3 2020$192,418,000
+9.5%
1,862,168
-16.2%
0.01%0.0%
Q2 2020$175,772,000
+39.7%
2,222,710
+2.2%
0.01%
+18.2%
Q1 2020$125,833,000
+13.0%
2,174,781
+5.4%
0.01%
+37.5%
Q4 2019$111,347,000
+15.2%
2,063,889
+11.7%
0.01%
+14.3%
Q3 2019$96,634,000
-22.0%
1,848,386
-27.9%
0.01%
-22.2%
Q2 2019$123,865,000
+9.8%
2,563,965
+14.8%
0.01%0.0%
Q1 2019$112,830,000
-3.2%
2,233,381
+13.6%
0.01%
-18.2%
Q4 2018$116,584,000
-6.5%
1,966,661
+3.9%
0.01%
+10.0%
Q3 2018$124,639,000
+25.3%
1,893,306
-3.9%
0.01%
+25.0%
Q2 2018$99,451,000
+9.2%
1,969,803
+13.9%
0.01%0.0%
Q1 2018$91,089,000
+31.0%
1,730,119
+15.6%
0.01%
+33.3%
Q4 2017$69,557,000
+21.6%
1,496,791
+5.8%
0.01%
+20.0%
Q3 2017$57,219,000
+22.7%
1,414,571
+2.8%
0.01%
+25.0%
Q2 2017$46,647,000
+10.6%
1,375,587
-5.3%
0.00%0.0%
Q1 2017$42,180,000
+3.7%
1,452,472
+17.2%
0.00%0.0%
Q4 2016$40,687,000
-16.7%
1,238,972
-20.0%
0.00%
-20.0%
Q3 2016$48,854,000
+61.5%
1,549,338
+44.0%
0.01%
+66.7%
Q2 2016$30,249,000
-24.3%
1,075,876
-2.2%
0.00%
-25.0%
Q1 2016$39,969,000
+12.1%
1,099,602
+23.3%
0.00%0.0%
Q4 2015$35,668,000
-7.2%
891,518
-33.9%
0.00%0.0%
Q3 2015$38,422,000
-18.7%
1,348,755
-6.0%
0.00%
-20.0%
Q2 2015$47,277,000
+19.9%
1,434,834
+4.6%
0.01%
+25.0%
Q1 2015$39,429,000
+32.6%
1,371,131
+25.5%
0.00%
+33.3%
Q4 2014$29,741,000
+21.1%
1,092,246
-5.2%
0.00%0.0%
Q3 2014$24,564,000
-10.3%
1,152,657
-5.4%
0.00%0.0%
Q2 2014$27,375,000
-13.7%
1,219,071
-2.9%
0.00%
-25.0%
Q1 2014$31,729,000
+3.4%
1,255,568
-19.2%
0.00%
+100.0%
Q4 2013$30,694,000
+82.6%
1,553,363
+76.1%
0.00%0.0%
Q3 2013$16,806,000
+20.1%
882,224
-9.1%
0.00%0.0%
Q2 2013$13,997,000970,4020.00%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Broadfin Capital, LLC 2,080,519$44,336,0004.65%
GREAT POINT PARTNERS LLC 290,000$6,180,0002.65%
FIDUCIARY MANAGEMENT ASSOCIATES LLC 651,884$13,892,0000.99%
Matarin Capital Management, LLC 85,003$1,811,414,0000.83%
KINGDON CAPITAL MANAGEMENT, L.L.C. 407,000$8,673,0000.39%
ICON ADVISERS INC/CO 258,478$5,508,0000.32%
RMB Capital Management, LLC 178,204$3,798,0000.23%
NEW AMSTERDAM PARTNERS LLC/NY 159,470$3,398,0000.23%
GLOBEFLEX CAPITAL L P 94,016$2,003,0000.23%
Convergence Investment Partners, LLC 58,672$1,250,0000.17%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders